Literature DB >> 11313907

G protein coupled receptor signaling through the Src and Stat3 pathway: role in proliferation and transformation.

P T Ram1, R Iyengar.   

Abstract

Extracellular signals when routed through signaling pathways that use heterotrimeric G proteins can engage multiple signaling pathways leading to diverse biological consequences. One locus at which signal sorting occurs is at the level of G proteins. G protein alpha-subunits appear to be capable of interacting with different effectors leading to engagement of distinct signaling pathways. Regulation of different pathways in turn leads to different biological outcomes. The process of neoplastic transformation is controlled to a large extent through the activation and inhibition of signaling pathways. Signaling pathways such as the Ras-MAPK, v-Src-Stat3 pathways are activated in the process of transformation. Expression of activated Galpha subunits have been shown to cause transformation of cells. While activation of the MAPK 1,2 pathway by various Galpha subunits has been reported for several years, recent studies show the activation and involvement of Src and Stat3 pathways in Galphao and Galphai mediated transformation of cells. Recent studies also suggest that both Galphai and Galphas may be able to interact with and activate Src. The activation of Src and Stat3 by G proteins has also been demonstrated by ligand-induced activation of G protein receptors. So increasingly it is becoming clear that the Src and Stat3 pathways are potential effectors for G proteins and that they may play a role in G protein function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313907     DOI: 10.1038/sj.onc.1204186

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.

Authors:  Paul A Johnston; Malabika Sen; Yun Hua; Daniel P Camarco; Tong Ying Shun; John S Lazo; Gabriela Mustata Wilson; Lynn O Resnick; Matthew G LaPorte; Peter Wipf; Donna M Huryn; Jennifer R Grandis
Journal:  Assay Drug Dev Technol       Date:  2015-09       Impact factor: 1.738

2.  Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex.

Authors:  N A Muma; R K Singh; M S Vercillo; D N D'Souza; B Zemaitaitis; F Garcia; K J Damjanoska; Y Zhang; G Battaglia; L D Van de Kar
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

3.  Lyn kinase promotes erythroblast expansion and late-stage development.

Authors:  Vinit G Karur; Clifford A Lowell; Peter Besmer; Valter Agosti; Don M Wojchowski
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

4.  Expression, purification, and bioactivity of GST-fused v-Src from a bacterial expression system.

Authors:  Xing-Guo Gong; Jing Ji; Jie Xie; Yuan Zhou; Jun-Yan Zhang; Wen-Tao Zhong
Journal:  J Zhejiang Univ Sci B       Date:  2006-01       Impact factor: 3.066

5.  Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia.

Authors:  Hai T Ngo; Abdel Kareem Azab; Mena Farag; Xiaoying Jia; Molly M Melhem; Judith Runnels; Aldo M Roccaro; Feda Azab; Antonio Sacco; Xavier Leleu; Kenneth C Anderson; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

6.  High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.

Authors:  Paul A Johnston; Malabika Sen; Yun Hua; Daniel Camarco; Tong Ying Shun; John S Lazo; Jennifer R Grandis
Journal:  Assay Drug Dev Technol       Date:  2013-10-15       Impact factor: 1.738

7.  The bone marrow microenvironment in waldenstrom macroglobulinemia.

Authors:  Irene M Ghobrial; Patricia Maiso; Abdelkareem Azab; Yang Liu; Yong Zhang; Ghayas Issa; Feda Azab; Antonio Sacco; Phong Quang; Hai Ngo; Aldo Roccaro
Journal:  Ther Adv Hematol       Date:  2011-08

8.  RNA-seq reveals determinants of sensitivity to chemotherapy drugs in esophageal carcinoma cells.

Authors:  Li-Xin Yang; Bai-Ling Li; Xiao-Hong Liu; Yang Yuan; Chao-Jing Lu; Rui Chen; Jian Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 9.  STAT3 signaling: anticancer strategies and challenges.

Authors:  Paul A Johnston; Jennifer R Grandis
Journal:  Mol Interv       Date:  2011-02

Review 10.  Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.

Authors:  Jong Hun Lee; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Ah-Ng Tony Kong
Journal:  Pharmacol Ther       Date:  2012-10-03       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.